Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human ADA Protein, N-His

Catalog #:   YHB88701 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P00813
Protein length: Lys11-Val280
Overview

Catalog No.

YHB88701

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Lys11-Val280

Predicted molecular weight

32.47 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P00813

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Adenosine aminohydrolase, Adenosine deaminase, ADA1, ADA

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human ADA protein
References

IL-6R Signaling Is Associated with PAD4 and Neutrophil Extracellular Trap Formation in Patients with STEMI., PMID:40508157

Impact of positive control binding properties on anti-drug antibody assay performance., PMID:40501387

Polybacterial intracellular macromolecules shape single-cell inflammatory profiles in upper airway epithelia., PMID:40494852

Immunogenicity risk mitigation of therapeutic proteins with translational immunogenicity, analytical characterization, and regulatory insight., PMID:40494415

Structural studies on ribosomes of differentially macrolide-resistant Staphylococcus aureus strains., PMID:40490363

Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment., PMID:40488894

Factors Impacting the Immunogenicity of Etrolizumab & Clinical Consequences., PMID:40481373

Automation of Anti-Drug Antibody Enrichment Using Streptavidin PhyTip® Columns for Sample Pretreatment in an Immunogenicity Assay., PMID:40481247

Distinct proteomic signatures in Ethiopians predict acute and long-term sequelae of COVID-19., PMID:40475767

Adenosine deaminase mediates endothelial inflammation via an ADA1-CD26 interaction in post-COVID., PMID:40469975

Individual variations in glycemic responses to carbohydrates and underlying metabolic physiology., PMID:40467897

Functional and distinct roles of Piezo2-mediated mechanotransduction in dental primary afferent neurons., PMID:40461462

Quantifying the Mutational Landscape of Retroviral and Lentiviral Vectors in Gene Therapy Patients., PMID:40450520

Clinical prediction model by machine learning to determine the results of maternal dietary avoidance in food protein-induced allergic proctocolitis infants., PMID:40453225

Enzyme replacement therapy using a modified α-N-acetylgalactosaminidase to suppress progressive glycolipid accumulation and escape from antidrug antibody formation in young human NAGA-transgenic/Gla-knockout mice., PMID:40446427

Clinical Response to Adalimumab Therapy and Its Determinants in Patients With Radiographic Axial Spondyloarthritis: A Prospective Real-World Study in Taiwan., PMID:40443026

Impact of vitamin D on glycemic control and microvascular complications in type 2 diabetes: A cross-sectional study., PMID:40435133

Diagnostic Performance of Clinical Metagenomic Next-Generation Sequencing for Suspected Central Nervous System Infections in a Municipal Hospital: A Retrospective Study in China., PMID:40432811

Efficacy and safety of dual-targeted therapy for refractory inflammatory bowel disease: a retrospective case series from three tertiary general hospitals in China., PMID:40421289

Microvascular complications in prediabetes: a systematic review & meta-analysis., PMID:40419194

Adenosine-Triggered Dynamic and Transient Aptamer-Based Networks Integrated in Liposome Protocell Assemblies., PMID:40403280

Interplay between pharmacokinetics and immunogenicity of therapeutic proteins: stepwise development of a bidirectional joint pharmacokinetics-anti-drug antibodies model., PMID:40399699

Bioinformatic discovery of type 11 secretion system (T11SS) cargo across the Proteobacteria., PMID:40397007

Extracellular Vesicle-Mediated Delivery of 20S Proteasomes Enhances Tau Degradation in Recipient Cells., PMID:40384174

Short-Term Immunosuppression in Rats Induces Prolonged Immune Tolerance Towards a Human Monoclonal Antibody, Erenumab., PMID:40379907

An evaluation of distinct adeno-associated virus vector strategies for driving transgene expression in spinal inhibitory neurons of the rat., PMID:40376611

Compromised adenosine-A2AR axis contributes to recurrent spontaneous abortion by promoting proinflammatory macrophage polarization., PMID:40373597

Target tolerance improvement of the immunogenicity assay developed for analysing samples from clinical trials of RGB-14, a proposed biosimilar to Prolia/Xgeva., PMID:40368321

Identification and Exploration of Pyroptosis-Related Genes in Macrophage Cells Reveal Necrotizing Enterocolitis Heterogeneity Through Single-Cell and Bulk-Sequencing., PMID:40362275

Pleural Fluid Biomarkers of Pediatric Parapneumonic Effusion., PMID:40361904

Method development for the detection of anti-drug antibodies against a therapeutic peptide: assay format selection., PMID:40346877

Development of a 5-Year Risk Prediction Model for Transition From Prediabetes to Diabetes Using Machine Learning: Retrospective Cohort Study., PMID:40344663

Statistical Tutorial for Cut-Point Determination in Immunogenicity Studies., PMID:40344492

Evaluating the Accuracy and Clinical Utility of AFIAS-10 Point of Care Versus Enzyme-Linked Immunosorbent Assay in Therapeutic Drug Monitoring of Infliximab and Adalimumab., PMID:40341590

Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice., PMID:40335415

Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial., PMID:40332939

The Yeast Gsk-3 Kinase Mck1 Is Necessary for Cell Wall Remodeling in Glucose-Starved and Cell Wall-Stressed Cells., PMID:40332024

Primary adrenal insufficiency caused by pseudo-neonatal adrenoleukodystrophy associated with biallelic ACOX1 mutations., PMID:40326779

Expanding the clinical utility of reporter gene assay to infliximab biosimilars., PMID:40320158

Effect of modified starch-chitosan coating incorporated with Gongju extract on the shelf life of salted duck., PMID:40319970

Cutaneous and systemic improvements in psoriasis patients after different biologic treatments in a real-world longitudinal prospective study., PMID:40319105

HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease., PMID:40315028

Neurovirulent and non-neurovirulent strains of HIV-1 and their Tat proteins induce differential cytokine-chemokine profiles., PMID:40313367

HIV-1 infection facilitates Alzheimer's disease pathology in humanized APP knock-in immunodeficient mice., PMID:40309515

[ADA2, an Adenosine Deaminase Isozyme Acting as a Regulator of Autoinflammation]., PMID:40307021

Adenosine deaminase promotes goose astrovirus genotype II replication in GEF cells., PMID:40305933

Capillary Glycated Hemoglobin A1c Percentiles and the Risk Factors Associated with Abnormal HbA1c among Chinese Children Aged 3-12 Years., PMID:40302958

PKA plays a conserved role in regulating gene expression and metabolic adaptation by phosphorylating Rpd3/HDAC1., PMID:40301306

The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Subcutaneous Administration of a Novel Anti-NGF Monoclonal Antibody (AK115) in Healthy Participants: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase I Clinical Trial., PMID:40297315

Water-directed pinning is key to tau prion formation., PMID:40294272

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human ADA Protein, N-His [YHB88701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only